CN115109093A - 基于亚膦酸酯-亚磷酸酯的配体 - Google Patents

基于亚膦酸酯-亚磷酸酯的配体 Download PDF

Info

Publication number
CN115109093A
CN115109093A CN202210274306.0A CN202210274306A CN115109093A CN 115109093 A CN115109093 A CN 115109093A CN 202210274306 A CN202210274306 A CN 202210274306A CN 115109093 A CN115109093 A CN 115109093A
Authority
CN
China
Prior art keywords
butene
compound according
tert
compound
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210274306.0A
Other languages
English (en)
Inventor
A·C·萨勒
R·弗兰克
A·布拉彻
D·福里达格
A·马科维奇
P·库克米尔茨克
J·克诺萨亚
D·塞伦特
A·博尔纳
K·罗麦克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Evonik Operations GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Operations GmbH filed Critical Evonik Operations GmbH
Publication of CN115109093A publication Critical patent/CN115109093A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65746Esters of oxyacids of phosphorus the molecule containing more than one cyclic phosphorus atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6568Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/65719Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonous acid derivative
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1845Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing phosphorus
    • B01J31/1885Ligands comprising two different formal oxidation states of phosphorus in one at least bidentate ligand, e.g. phosphite/phosphinite
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • C07C45/505Asymmetric hydroformylation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/32Addition reactions to C=C or C-C triple bonds
    • B01J2231/321Hydroformylation, metalformylation, carbonylation or hydroaminomethylation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0238Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
    • B01J2531/0241Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/822Rhodium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本申请涉及基于亚膦酸酯‑亚磷酸酯的配体,和其在加氢甲酰化中的用途。

Description

基于亚膦酸酯-亚磷酸酯的配体
本发明涉及基于亚膦酸酯(Phosphonit)-亚磷酸酯的配体,和其在加氢甲酰化中的用途。
WO 2008/071508 A1描述了使用双亚磷酸酯配体的加氢甲酰化方法。尤其描述了配体(D-1)的使用。
Figure BDA0003553246770000011
本发明所基于的技术问题是提供与现有技术已知的化合物相比在烯烃的加氢甲酰化中提供增加的产率的新型化合物。
该问题通过根据权利要求1的化合物解决。
式(I)的化合物:
Figure BDA0003553246770000012
其中
R1、R2、R3、R4、R5、R6、R7、R8各自独立地选自-H、-(C1-C12)-烷基、-O-(C1-C12)-烷基。
术语-(C1-C12)-烷基和-O-(C1-C12)-烷基包括具有1至12个碳原子的直链和支化的烷基。这些优选是-(C1-C8)-烷基或-O-(C1-C8)-烷基,特别优选-(C1-C4)-烷基或-O-(C1-C4)-烷基。
在一个实施方案中,R5和R8为-(C1-C12)-烷基。
在一个实施方案中,R5和R8为-tertBu。
在一个实施方案中,R6、R7选自-(C1-C12)-烷基、-O-(C1-C12)-烷基。
在一个实施方案中,R6和R7为-OCH3或-tertBu。
在一个实施方案中,R1、R2、R3、R4选自-H、-(C1-C12)-烷基。
在一个实施方案中,R1、R2、R3、R4为-H或-tertBu。
在一个实施方案中,该化合物具有结构(1)至(3)之一:
Figure BDA0003553246770000021
除了化合物本身之外,还要求保护其中使用该化合物的方法。
所述方法包含以下步骤:
a)预置入烯属不饱和化合物;
b)加入如上所述的化合物和包含Rh的物质;
c)供入H2和CO,
d)加热a)-c)的反应混合物,使烯属不饱和化合物转化为醛。
在该方法中,方法步骤a)、b)和c)可以以任何所需顺序进行。然而,通常在步骤a)和b)中已经预置入反应参与物之后加入CO。此外,CO也可以以多步供入,从而例如首先进料一部分CO,然后加热混合物,然后再进料另一部分CO。
在根据本发明方法中用作反应物的烯属不饱和化合物含有一个或多个碳-碳双键。为了简化,这些化合物在下文中也称为烯烃。双键可以是位于末端的或内部的。
在该方法的一个变体中,烯属不饱和化合物不包含除碳-碳双键之外的任何其它官能团。
在该方法的一个变体中,烯属不饱和化合物选自:乙烯、丙烯、1-丁烯、顺式和/或反式-2-丁烯、异丁烯、1,3-丁二烯、1-戊烯、顺式和/或反式-2-戊烯、2-甲基-1-丁烯、3-甲基-1-丁烯、2-甲基-2-丁烯、己烯、四甲基乙烯、庚烯、1-辛烯、2-辛烯、二正丁烯或其混合物。
在该方法的一个变体中,包含Rh的物质选自Rh(acac)(CO)2
[(acac)Rh(COD)](Umicore,acac=乙酰丙酮酸阴离子;COD=1,5-环辛二烯)、Rh4CO12
在该方法的一个变体中,在方法步骤c)中在1-6MPa(10-60巴)的压力下供入CO。
在该方法的一个变体中,在方法步骤d)中将反应混合物加热至80℃至160℃的温度。
下面将参照实施例更详细地说明本发明。
6-((3,3'-二叔丁基-2'-((4,6-二叔丁基苯并[d][1,3,2]二氧磷杂环戊烯 (dioxaphosphol)-2-基)氧基)-5,5'-二甲氧基-[1,1'-联苯基]-2-基)氧基)-6H-二苯并 [c,e][1,2]氧磷杂苯(oxaphosphinin)(1)的合成
Figure BDA0003553246770000041
向已冷却至0℃的2'-((6H-二苯并[c,e][1,2]氧磷杂苯-6-基)氧基)-3,3'-二叔丁基-5,5'-二甲氧基-[1,1'-联苯基]-2-醇(1.000g;1.7965mmol)和三乙胺(0.5ml)在16mlTHF中的混合物中滴加4,6-二叔丁基-2-氯苯并[d][1,3,2]二氧磷杂环戊烯(0.5151g;1.7965mmol)在5ml的THF中的溶液。在室温下搅拌过夜并过滤,将滤液减压浓缩至干。使得到的固体在50℃/0.1毫巴下干燥2小时,然后溶于16ml热乙腈中。将冷却后形成的固体滤出,用很少量冷乙腈洗涤,并在50℃/0.1毫巴下干燥4小时。产率:0.807g(1.098mmol,61%)。
元素分析(对于C48H56O7P2的计算值=806.911g/mol):C=71.56(71.45);H=6.96(6.99);P=7.44(7.68)。
ESI-TOF HRMS:m/z=807.3586;[M++H],计算的m/z=807.35799。
31P NMR(CD2Cl2):δ125.4(d,JPP=62Hz);126.9(d,JPP=33Hz);127.6(d,JPP=51Hz);129.2(d,JPP=96Hz);130.4(d,JPP=51Hz);133.2(d,JPP=62Hz);134.2(d,JPP=96Hz);135.0(d,JPP=33Hz)ppm。
1H NMR(CD2Cl2):δ1.09;1.15;1.17;1.29;1.30;1.31;1.32;1.34;1.35;1.36;1.36;1.37;1.38;1.38;1.39;1.39;1.40;1.41;1.43;1.44;1.47;1.49;1.52;1.58;3.38;3.53;3.62;3.68;3.81;3.83;3.95;3.96ppm。
6-((3,3'-二叔丁基-2'-((5-(叔丁基)苯并[d][1,3,2]二氧磷杂环戊烯-2-基)氧 基)-5,5'-二甲氧基-[1,1'-联苯基]-2-基)氧基)-6H-二苯并[c,e][1,2]氧磷杂苯(3)的合
Figure BDA0003553246770000051
在0℃下向2'-((6H-二苯并[c,e][1,2]氧磷杂苯-6-基)氧基)-3,3'-二叔丁基-5,5'-二甲氧基-[1,1'-联苯基]-2-醇(,5g;0.8982mmol)和三乙胺(0.25ml)在8ml THF中的混合物中滴加5-(叔丁基)-2-氯苯并[d][1,3,2]二氧磷杂环戊烯(0.2071g;0.8982mmol)在3ml THF中的溶液。在室温下搅拌过夜并过滤,将滤液减压浓缩至干。使得到的固体在50℃/0.1毫巴下干燥2小时,然后溶于6.3ml热乙腈中。将在低温冷柜中储存后形成的固体滤出,用很少量冷乙腈洗涤,并在50℃/0.1毫巴下干燥4小时。产率:0.168g(0.274mmol,30%)。
元素分析(对于C44H48O7P2的计算值=750.8042g/mol):C=70.37(70.39);H=6.26(6.44);P=8.12(8.25)。
ESI-TOF HRMS:m/z=773.2778;[M++Na],计算的m/z=773.27733。
31P NMR(CD2Cl2):δ126.2(d,JPP=49Hz);126.6(d,JPP=43Hz);128.3(d,JPP=86Hz);128.4(d,JPP=79Hz);134.2(d,JPP=79Hz);134.7(d,JPP=86Hz);136.0(d,JPP=49Hz);136.3(d,JPP=43Hz)ppm。
1H NMR(CD2Cl2):δ1.13;1.13;1.26;1.27;1.31;1.33;1.36;1.36;1.37;1.38;1.49;1.51ppm。
6-((3,3',5,5'-四-叔丁基-2'-((5-(叔丁基)苯并[d][1,3,2]二氧磷杂环戊烯- 2-基)氧基)-[1,1'-联苯基]-2-基)氧基)-6H-二苯并[c,e][1,2]氧磷杂苯(3)的合成
Figure BDA0003553246770000061
在0℃下向2'-((6H-二苯并[c,e][1,2]氧磷杂苯-6-基)氧基)-3,3',5,5'-四叔丁基-[1,1'-联苯基]-2-醇(0.761g;1.250mmol)和吡啶(0.15ml)在10ml THF中的混合物中滴加5-(叔丁基)-2-氯苯并[d][1,3,2]二氧磷杂环戊烯(0.2883g;1.250mmol)在2ml THF中的溶液。在室温下搅拌过夜并过滤,将滤液减压浓缩至干。使得到的固体在50℃/0.1毫巴下干燥2小时,然后与8ml庚烷一起搅拌。滤出剩余的固体,用很少量冷庚烷洗涤并在50℃/0.1毫巴下干燥4小时。产率:0.720g(1.125mmol,90%)。
元素分析(对于C50H60O5P2的计算值=802.967g/mol):C=74.90(74.79);H=7.55(7.53);P=7.65(7.72)。
ESI-TOF HRMS:m/z=803.4004;[M++H],计算的m/z=803.39945。
31P NMR(CD2Cl2):δ125.8(d,JPP=29Hz);126.1(d,JPP=20Hz);126.2(d,JPP=28Hz);126.4(d,JPP=20Hz);132.9(d,JPP=29Hz);133.4(d,JPP=28Hz);136.8(d,JPP=20Hz);137.1(d,JPP=20Hz)ppm。
催化实验
在Premex Reactor AG,Lengau(瑞士)公司的200ml高压釜中进行加氢甲酰化,该高压釜装配有保压阀、气体流量计、喷射搅拌器和压力吸管。为了使水分和氧气的影响最小化,使用作溶剂的甲苯在Pure Solv.MD-7系统中纯化并在氩气下储存。将用作底物的烯烃顺/反-2-戊烯(Aldrich)在钠上加热回流并在氩气下蒸馏。在氩气氛下,在高压釜中混合催化剂前体和配体的各自的甲苯溶液。将[(acac)Rh(COD)](Umicore,acac=乙酰丙酮酸阴离子;COD=1,5-环辛二烯)用作催化剂前体。在12巴下于搅拌(1500转/分)下加热高压釜,最终压力为20巴。在达到反应温度后,通过在压力吸管中调节得的正压将烯烃注入高压釜。反应在恒压(来自Bronkhorst(荷兰)公司的闭环压力调节器(Nachdruckregler))下进行4小时。在反应时间结束时,将高压釜冷却至室温,在搅拌的同时减压并用氩气吹扫。每种情形下在关闭搅拌器后立即取出1ml反应混合物,用10ml戊烷将其稀释并通过气相色谱分析:HP5890Series II plus,PONA,50m x 0.2mm x 0.5μm。
使用根据本发明的化合物(1)至(3)和使用对比配体(D-1)进行反应。
Figure BDA0003553246770000071
反应条件:
烯烃:2-戊烯,溶剂:甲苯,铑的质量比例:100ppm,p:20巴,T:120℃,t:4h,Rh:配体比例=1:2。
结果汇编于下表中:
配体 醛的产率[%]
1* 94
2* 98
3* 99
D-1 14
*根据本发明的化合物
如实验结果所示,根据本发明的化合物解决了该问题。

Claims (13)

1.式(I)的化合物:
Figure FDA0003553246760000011
其中
R1、R2、R3、R4、R5、R6、R7、R8各自独立地选自-H、-(C1-C12)-烷基、-O-(C1-C12)-烷基。
2.根据权利要求1的化合物,
其中R5和R8为-(C1-C12)-烷基。
3.根据权利要求1和2任一项的化合物,
其中R5和R8为-tertBu。
4.根据权利要求1-3任一项的化合物,
其中R6、R7选自-(C1-C12)-烷基、-O-(C1-C12)-烷基。
5.根据权利要求1-4任一项的化合物,
其中R6和R7为-OCH3或-tertBu。
6.根据权利要求1-5任一项的化合物,
其中R1、R2、R3、R4选自-H、-(C1-C12)-烷基。
7.根据权利要求1-6任一项的化合物,
其中R1、R2、R3、R4为-H或-tertBu。
8.根据权利要求1-7任一项的化合物,
其中该化合物具有结构(1)至(3)之一:
Figure FDA0003553246760000021
9.方法,包含以下方法步骤:
a)预置入烯属不饱和化合物;
b)加入根据权利要求1-8任一项的化合物和包含Rh的物质;
c)供入H2和CO,
d)加热a)-c)的反应混合物,使烯烃转化为醛。
10.根据权利要求9的方法:
其中方法步骤a)中的烯属不饱和化合物选自:乙烯、丙烯、1-丁烯、顺式和/或反式-2-丁烯、异丁烯、1,3-丁二烯、1-戊烯、顺式和/或反式-2-戊烯、2-甲基-1-丁烯、3-甲基-1-丁烯、2-甲基-2-丁烯、己烯、四甲基乙烯、庚烯、1-辛烯、2-辛烯、二正丁烯或其混合物。
11.根据权利要求9和10任一项的方法,
其中包含Rh的物质选自:Rh(acac)(CO)2、[(acac)Rh(COD)](Umicore,acac=乙酰丙酮酸阴离子;COD=1,5-环辛二烯)、Rh4CO12
12.根据权利要求9-11任一项的方法,
其中在方法步骤c)中在1-6MPa(10-60巴)的压力下供入CO。
13.根据权利要求9-12任一项的方法,
其中在方法步骤d)中将所述反应混合物加热至80℃至160℃的温度。
CN202210274306.0A 2021-03-18 2022-03-18 基于亚膦酸酯-亚磷酸酯的配体 Pending CN115109093A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21163479.5A EP4059940A1 (de) 2021-03-18 2021-03-18 Liganden auf basis von phosphonit-phosphiten
EP21163479.5 2021-03-18

Publications (1)

Publication Number Publication Date
CN115109093A true CN115109093A (zh) 2022-09-27

Family

ID=75108244

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210274306.0A Pending CN115109093A (zh) 2021-03-18 2022-03-18 基于亚膦酸酯-亚磷酸酯的配体

Country Status (4)

Country Link
US (1) US20220298189A1 (zh)
EP (1) EP4059940A1 (zh)
KR (1) KR20220130612A (zh)
CN (1) CN115109093A (zh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19810794A1 (de) * 1998-03-12 1999-09-16 Basf Ag Katalysator, umfassend einen Komplex eines Metalls der VIII. Nebengruppe auf Basis eines Phosphonitliganden und Verfahren zur Hydroformylierung
DE102006058682A1 (de) 2006-12-13 2008-06-19 Evonik Oxeno Gmbh Bisphosphitliganden für die übergangsmetallkatalysierte Hydroformylierung

Also Published As

Publication number Publication date
KR20220130612A (ko) 2022-09-27
US20220298189A1 (en) 2022-09-22
EP4059940A1 (de) 2022-09-21

Similar Documents

Publication Publication Date Title
US5710344A (en) Process to prepare a linear aldehyde
KR100714323B1 (ko) 다좌 포스파이트 리간드를 함유하는 촉매 조성물을 사용하는 촉매 방법
KR100570852B1 (ko) 말단알데히드의제조방법
US5874641A (en) Process to prepare a terminal aldehyde
CN115109093A (zh) 基于亚膦酸酯-亚磷酸酯的配体
KR100671389B1 (ko) 다좌 포스파이트 리간드를 사용하는 히드로포르밀화 방법
CN115109092A (zh) 基于苯频哪醇和1,3-丙二醇的双亚磷酸酯配体
CN115109091A (zh) 基于苯频哪醇的具有开放侧向结构单元的双亚磷酸酯配体
CN115109094A (zh) 基于苯频哪醇的双亚磷酸酯配体
TW202214550A (zh) 基於順-丁烯-1,4-二醇之新穎二亞磷酸酯
EP1534657B1 (en) Process for preparing aldehyde compounds
KR20240104017A (ko) 디시클로헥실포스피노 라디칼을 갖는 디포스파이트
US20240218001A1 (en) Diphosphites with substituents in the cis position
US20240218000A1 (en) Diphosphites with substituents in the trans position
US20240217998A1 (en) Diphosphites with a dicyclohexylphosphino radical
TW202214666A (zh) 6,6’-(〔1,1’-聯苯基〕-2,3’-二基雙(氧基))雙二苯并〔d,f〕〔1,3,2〕二磷呯
CN118255810A (zh) 在反式位置具有取代基的二亚磷酸酯
CN118255811A (zh) 具有2-萘基的二亚磷酸酯
KR100714324B1 (ko) 다좌 포스파이트 리간드, 및 이를 함유하는 촉매 조성물

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication